Vontobel Holding Ltd. Increases Stock Position in DaVita Inc. (NYSE:DVA)

Vontobel Holding Ltd. grew its stake in shares of DaVita Inc. (NYSE:DVA) by 17.2% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 2,243 shares of the company’s stock after acquiring an additional 329 shares during the quarter. Vontobel Holding Ltd.’s holdings in DaVita were worth $368,000 as of its most recent SEC filing.

Several other large investors also recently bought and sold shares of the business. Global Assets Advisory LLC purchased a new position in DaVita in the 1st quarter worth approximately $2,360,000. Gateway Investment Advisers LLC purchased a new stake in shares of DaVita during the 1st quarter worth $218,000. Atlas Capital Advisors LLC lifted its stake in shares of DaVita by 137.0% during the 1st quarter. Atlas Capital Advisors LLC now owns 6,254 shares of the company’s stock worth $863,000 after purchasing an additional 3,615 shares during the last quarter. Fox Hill Wealth Management lifted its stake in shares of DaVita by 138.4% during the 1st quarter. Fox Hill Wealth Management now owns 15,734 shares of the company’s stock worth $2,172,000 after purchasing an additional 9,135 shares during the last quarter. Finally, Dumont & Blake Investment Advisors LLC lifted its stake in shares of DaVita by 2.1% during the 1st quarter. Dumont & Blake Investment Advisors LLC now owns 8,290 shares of the company’s stock worth $1,144,000 after purchasing an additional 170 shares during the last quarter. 90.12% of the stock is currently owned by institutional investors.

DaVita Stock Performance

Shares of NYSE:DVA opened at $163.16 on Wednesday. The company has a debt-to-equity ratio of 9.94, a current ratio of 1.16 and a quick ratio of 1.12. The business’s 50 day moving average price is $157.10 and its 200-day moving average price is $144.89. The firm has a market capitalization of $14.31 billion, a PE ratio of 18.54, a P/E/G ratio of 0.93 and a beta of 0.87. DaVita Inc. has a 1 year low of $75.47 and a 1 year high of $168.50.

DaVita (NYSE:DVA) last released its quarterly earnings data on Tuesday, August 6th. The company reported $2.59 earnings per share for the quarter, topping analysts’ consensus estimates of $2.47 by $0.12. The company had revenue of $3.19 billion for the quarter, compared to analyst estimates of $3.15 billion. DaVita had a return on equity of 77.00% and a net margin of 6.86%. The firm’s revenue for the quarter was up 6.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.08 earnings per share. As a group, equities research analysts expect that DaVita Inc. will post 9.99 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities research analysts have commented on DVA shares. Bank of America increased their price target on DaVita from $139.00 to $145.00 and gave the company an “underperform” rating in a research note on Wednesday, August 7th. UBS Group increased their price objective on DaVita from $169.00 to $175.00 and gave the company a “buy” rating in a report on Thursday, August 8th. TD Cowen lifted their price target on DaVita from $139.00 to $150.00 and gave the company a “hold” rating in a research report on Wednesday, July 24th. Finally, Truist Financial lifted their price target on DaVita from $165.00 to $175.00 and gave the company a “hold” rating in a research report on Monday, October 7th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $159.00.

Insiders Place Their Bets

In other DaVita news, insider Kathleen Alyce Waters sold 7,857 shares of the business’s stock in a transaction on Tuesday, August 13th. The stock was sold at an average price of $146.21, for a total transaction of $1,148,771.97. Following the transaction, the insider now owns 83,011 shares of the company’s stock, valued at approximately $12,137,038.31. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. In other news, insider Kathleen Alyce Waters sold 7,857 shares of the company’s stock in a transaction on Tuesday, August 13th. The stock was sold at an average price of $146.21, for a total value of $1,148,771.97. Following the transaction, the insider now owns 83,011 shares of the company’s stock, valued at $12,137,038.31. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, COO Michael David Staffieri sold 9,539 shares of the company’s stock in a transaction on Thursday, August 15th. The shares were sold at an average price of $150.03, for a total value of $1,431,136.17. Following the completion of the transaction, the chief operating officer now directly owns 241,945 shares in the company, valued at approximately $36,299,008.35. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 173,482 shares of company stock valued at $27,387,069. Insiders own 2.00% of the company’s stock.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.